EN - Anglická CZ - Česká SK - Slovenská PL - Polská RO - Rumunská RU - Ruská TR - Turecká UA - Ukrajinská
EN - Anglická
  • CZ - Česká
  • SK - Slovenská
  • PL - Polská
  • RO - Rumunská
  • RU - Ruská
  • TR - Turecká
  • UA - Ukrajinská

BioEquin F, suspension for injection for horses

Homepage Products Veterinary products BioEquin F, suspension for injection for horses

Vaccine against equine influenza

type of preparative: Vaccines
target species animals: Horse

Active substances in one dose:  

Virus influenzae equorum inactivatum, strains:

A/Equi 2/Morava 95 ((European type)  min. 5 log2 HIT1

A/Equi 2/Brno 08 (American type, clade Florida 2)   min. 5 log2 HIT1

1 geometrical average of specific antibodies determinated by heamagglutination inhibition test in serum of guinea pigs

Injection suspension

Target species:

Horse – Equus caballus

Indication:

For active immunization of horses to reduce the occurrence of clinical signs caused by equine influenza virus and to reduce virus spreading after infection. 

Onset of immunity: 14 days after  primary  vaccination

Duration of immunity:  6 months  after primary vaccination and 12 months after third dose of vaccination

Dosage:

1 ml deep intramuscularly.

Primary vaccination course

First injection at the age  6 months, second injection is made 4 weeks later.

Revaccination

The first revaccination (third dose) is given 6 months after the primary vaccination course and further revaccination against influenza is carried out once in 12 months.

Revaccinate pregnant mares in the last trimester of pregnancy, no later than one month before the planned delivery

Shelf life:

33 months, after  the first opening in more doses: 10 hours.

Special storage precaution:

Store in a refrigerator (2 °C – 8 °C)

Package:

2 x 1 dose, 10 x 1 dose.

Not all pack sizes may be marketed.